Fiat to purchase entire equity interest of UAW Retiree Medical Benefits Trust in Chrysler Group

The UAW Retiree Medical Benefits Trust (Trust) is pleased to confirm that an agreement has been reached between the Trust's Independent Fiduciary and Fiat North America LLC regarding a purchase of the Trust's entire equity interest in Chrysler Group LLC.

We are very pleased that Fiat and the Trust's Independent Fiduciary were able to work together to reach an agreement on this important matter. The team at Brock Fiduciary Services worked with extraordinary diligence and professionalism to achieve the best possible outcome for the Trust and the retirees we serve.

"This agreement is in the best interests of the Trust's UAW Chrysler retiree members and their families who rely on the Trust to provide vital health care benefits," said Robert Naftaly, chair of the Committee that governs the Trust. 

The Trust provides medical benefits to more than 117,000 UAW-represented Chrysler retirees, surviving spouses and dependents, and will provide post-retirement benefits to eligible UAW-represented Chrysler employees and their dependents upon their retirement. 

The UAW Retiree Medical Benefits Trust is the largest non-governmental purchaser of retiree health care benefits in the United States, providing health care benefits to over 779,000 UAW retirees and dependents from General Motors, Ford and Chrysler.

Source:

UAW Retiree Medical Benefits Trust

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare